TFE3

Information TFE3

Description

This gene encodes a basic helix-loop-helix domain-containing transcription factor that binds MUE3-type E-box sequences in the promoter of genes. The encoded protein promotes the expression of genes downstream of transforming growth factor beta (TGF-beta) signaling. This gene may be involved in chromosomal translocations in renal cell carcinomas and other cancers, resulting in the production of fusion proteins. Translocation partners include PRCC (papillary renal cell carcinoma), NONO (non-POU domain containing, octamer-binding), and ASPSCR1 (alveolar soft part sarcoma chromosome region, candidate 1), among other genes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]

Full Name

transcription factor binding to IGHM enhancer 3

Source NCBI

ReMap Statistics

Datasets
1
Biotypes
1
Peaks
71,138
Non-redundant peaks
71,138

TF Classification

Super Class
NA
Class
NA
Familly
NA
Sub Familly
NA

Source TFClass

External IDs

JASPAR
MA0831
Ensembl
ENSG00000068323
UniProt
P19532
Genevisible
P19532
RefSeq
NM_001282142
Aliases
RCCP2; RCCX1; TFEA; bHLHe33
All peaks TFE3
Download BED file
Non redundant peaks TFE3
Download BED file
SEQUENCES TFE3
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for TFE3

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
TFE3 Hep-G2 ENCODE Homo sapiens ENCSR589SNT 71,138
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.